As the COVID-19 outbreak continues to evolve, organizations are navigating the various stages of the M&A and transaction lifecycle to maximize their value. Whether acting as a buy- or sell-side participant, Kroll has a proven track record helping clients identify and investigate potential problems and assess the various financial and operational strategies available through every stage of a deal. Our team of experts is ready to assist and provide sound advice on distressed M&A, cash availability analysis, comprehensive due diligence, fairness opinions, disputes and restructuring considerations, among others.

Learn more about our COVID-19 risk management solutions.

M&A and Transactions Advisory
Kroll Institute Fellow Efraim Chalamish shares timely insights on the deal and sector landscape in Israel, as well as equity capital markets activity and the impact of SPACs in the region.
M&A Advisory

Kroll Institute Fellow Efraim Chalamish shares timely insights on the deal and sector landscape in Israel, as well as equity capital markets activity and the impact of SPACs in the region.

Dec 15, 2020

Israel Transactions Insights – Fall 2020
Play
European Chemicals Update – Q4 2020
M&A Advisory

European Chemicals Update – Q4 2020

Nov 27, 2020

by Andreas StoecklinPhilipp BoseDafydd EvansPaul TeutenJavier ZoidoJacques GiardJochem QuaakDavid AlthoffStephen BurtHoward JohnsonDavid LuKatsumi  Asai

European Chemicals Update – Q4 2020

ServicesStay Ahead with Kroll

Mergers and Acquisitions (M&A) Advisory

Mergers and Acquisitions (M&A) Advisory

Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.

Distressed M&A and Special Situations

Distressed M&A and Special Situations

Kroll professionals have advised hundreds of companies, investors and other stakeholders at all stages of distressed transactions and special situations.

Return to top